Patent №
US 12,640,235
Granted
2026-05-26
Filed 2022
Owner
Illumina, Inc.
Lab
—
AI components
0
Assignment
None on record
Dataset
AIPD
Application
17874158
The technology disclosed relates to splice site prediction and aberrant splicing detection. In particular, it relates to a splice site predictor that includes a convolutional neural network trained on training examples of donor splice sites, acceptor splice sites, and non-splicing sites. An input stage of the convolutional neural network feeds an input sequence of nucleotides for evaluation of target nucleotides in the input sequence. An output stage of the convolutional neural network translates analysis by the convolutional neural network into classification scores for likelihoods that each of the target nucleotides is a donor splice site, an acceptor splice site, and a non-splicing site.
Ownership
Illumina, Inc.